drugset / Trial / NCT00764660

Trial Investigating the Efficacy and Safety of SCH 900435 (Org 25935) in Relapse Prevention in Participants With Alcohol Dependence (P05718)

NCT00764660

Phase 2 Terminated 141 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the effects of SCH 900435 (Org 25935, MK-8435) on heavy drinking, safety and tolerability of SCH 900435 in participants with alcohol dependence.

Timeline

Start
2009-02-13
Primary completion
2010-05-28
Completion
2010-07-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Org 25935 Small molecule 12 mg Oral

Indications